Barinthus Biotherapeutics plc.
Ticker: 1828185
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2024 | Q3 FY2024 | Q2 FY2023 | Q2 FY2023 | Q1 FY2023 | Q1 FY2023 | Q3 FY2022 | Q3 FY2022 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 14.97+0.0% | 14.97+4436.4% | 0.33+0.0% | 0.33-29.8% | 0.47+0.0% | 0.47-92.4% | 6.17+0.0% | 6.17 |
| Total Income | 14.97+0.0% | 14.97+4436.4% | 0.33+0.0% | 0.33-29.8% | 0.47+0.0% | 0.47-92.4% | 6.17+0.0% | 6.17 |
| EXPENSES | ||||||||
| Expenditure | 24.35+0.0% | 24.35-8.7% | 26.67+0.0% | 26.67+21.5% | 21.95+0.0% | 21.95+1679.1% | -1.39-29.9% | -1.07 |
| Tax | 0.00 | 0.00+100.0% | -1.14+0.0% | -1.14-119.2% | -0.52+0.0% | -0.52+22.4% | -0.67+0.0% | -0.67 |
| PROFIT | ||||||||
| PBT | -8.13+0.0% | -8.13+67.4% | -24.96+0.0% | -24.96-33.2% | -18.74+0.0% | -18.74 | — | 7.55 |
| Net Profit | -8.11+0.0% | -8.11+65.9% | -23.80+0.0% | -23.80-30.9% | -18.18+0.0% | -18.18-320.6% | 8.24+0.0% | 8.24 |
| KEY METRICS | ||||||||
| OPM % | -62.66% | -62.66%+37.34pp | -100.00% | -100.00% | -100.00% | -100.00%-200.00pp | 100.00% | 100.00% |
| NPM % | -54.20% | -54.20%+45.79pp | -100.00% | -100.00% | -100.00% | -100.00%-200.00pp | 100.00% | 100.00% |
| EPS | -0.21+0.0% | -0.21+66.1% | -0.62+0.0% | -0.62-29.2% | -0.48+0.0% | -0.48-318.2% | 0.22+0.0% | 0.22 |
Corporate Events
Board MeetingBRNS
20262Jul
Board Meeting
Barinthus Biotherapeutics plc will hold its 2026 Annual Gene…
SEC Filing ↗ Board MeetingBRNS
202620May
Board Meeting
Shareholders voted on and approved the Scheme of Arrangement…
SEC Filing ↗ Board MeetingBRNS
20261May
Board Meeting
Appointment of Douglas Swirsky to the Board of Directors, ef…
SEC Filing ↗